Skip to main content
SVBI logo

SVBI — Investor Relations & Filings

Ticker · 1786 ISIN · TW0001786002 TW Manufacturing
Open in API
Filings indexed 1,687 across all filing types
Latest filing 2018-08-09 Regulatory Filings
Country TW Taiwan
Listing TW 1786

About SVBI

www.scivision.com.tw

SciVision Biotech Inc. is a specialized developer and manufacturer of advanced medical devices, focusing on the research and production of hyaluronic acid (HA) products. The company leverages its proprietary Crosslinked Hyaluronic Acid Platform (CHAP) technology to create high-performance solutions across multiple medical disciplines. Its core product portfolio includes subcutaneous fillers for facial aesthetics, intra-articular injections for orthopedic joint care, anti-adhesion gels for surgical applications, and vesical instillation solutions for urological treatments. By integrating specialized R&D capabilities with precision manufacturing, SciVision Biotech provides medical-grade HA applications designed to improve patient outcomes in aesthetics and therapeutic recovery. The company is committed to scientific innovation and the expansion of its patented technology to meet diverse clinical needs in the global healthcare market.

Recent filings

Filing Released Lang Actions
本公司"德撫癒"可吸收防沾黏凝膠("DEFEHERE" Absorbable Adhesion Barrier)取得台灣衛生福利部食品藥物 管理署(TFDA)核發上市許可證。
Regulatory Filings Classification · 95% confidence The document is a short announcement (951 characters) from a company named 科妍生物科技股份有限公司 (Koyan Biotechnology Co., Ltd.) regarding the approval of a medical product by the Taiwan Food and Drug Administration (TFDA). It is a factual disclosure about a regulatory approval event, not a financial report or detailed management discussion. There is no financial data, no mention of annual or quarterly results, no board changes, no voting results, no merger or acquisition activity, and no executive compensation details. The document is essentially a regulatory announcement about product approval. Given its short length and nature, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2018-08-09 Chinese
107年07月內部人持股異動(事後)
Director's Dealing Classification · 100% confidence The document contains detailed tables listing shareholdings of company insiders, including directors, supervisors, managers, and their related parties. It shows changes in shareholdings, types of shares held, and other related insider information. There is no indication of financial statements, earnings data, or management discussion. The content is focused on insider share transactions and holdings. This matches the definition of Director's Dealing (DIRS), which reports personal share transactions by company directors and executives (insider trades). The document length is sufficient and the content is substantive insider shareholding data, not just an announcement or summary. Therefore, the appropriate classification is DIRS.
2018-08-02 Chinese
107年07月董事會成員及持股
Director's Dealing Classification · 95% confidence The document is a detailed tabulation of shareholdings by insiders and related parties of the company 科妍生物科技股份有限公司. It lists shareholdings by directors, supervisors, managers, and other insiders, including pledged shares and shares held by spouses or minors. The document does not contain financial statements, earnings data, or management discussion. It is a disclosure of insider shareholdings and related information, which aligns with the definition of Director's Dealing (DIRS) filings, which report personal share transactions or holdings by company directors and executives. The document length is 2910 characters, which is relatively short but contains detailed insider shareholding data rather than just an announcement or a certification. Therefore, the best classification is DIRS with high confidence.
2018-08-02 Chinese
107年07月內部人持股轉讓(事前)
Director's Dealing Classification · 100% confidence The document is a tabular report detailing a share transfer by an insider (a manager) including dates, share quantities, and transfer methods. It specifically reports on a director or executive's personal share transactions. There is no indication of financial results, meeting materials, or regulatory announcements beyond insider dealing. The content matches the definition of Director's Dealing (DIRS), which covers reports of personal share transactions by company directors and executives.
2018-07-13 Chinese
107年6月營業收入
Regulatory Filings Classification · 90% confidence The document is a summary report of monthly and cumulative net operating revenue figures for a company named 科妍 for the period 民國107年06月 (June 2018). It includes comparative figures from the previous year and percentage changes. The document is short (765 characters) and contains financial data but is not a comprehensive financial report like an annual or interim report. It appears to be a regulatory disclosure of financial performance metrics, typical of a regulatory filing or a brief financial summary. There is no indication that this is an earnings release, annual report, or other detailed report. Given the nature and length, it fits best as a Regulatory Filing (RNS) which is a fallback category for miscellaneous filings that do not fit other categories.
2018-07-10 Chinese
107年6月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a listed company (科妍) reporting on the status of fund loans and endorsement guarantees for a specific month (June 2018, 民國107年06月). It contains tabular data showing zero balances and no guarantees. The content is very short (601 characters) and purely factual without any narrative or detailed financial statements. This type of document is a regulatory disclosure about financing and guarantees, typical of a Regulatory Filings (RNS) category, as it does not constitute a full financial report, audit, or earnings release. It is not an announcement of a report publication, nor a certification or management discussion. Therefore, the best fit is Regulatory Filings (RNS).
2018-07-10 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.